Gastric inhibitory polypeptide, also known as glucose-dependent insulinotropic polypeptide, is an inhibiting hormone of the secretin family of hormones. From Wikipedia
New preclinical data presented at ECO25 reveals tirzepatide’s transient energy expenditure boost and semaglutide’s initial metabolic slowdown, with both drugs’ effects reversing after treatment ends.
